Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
etanercept (enbrel) (1 trial)
Bone Neoplasms (Phase 3)
Cachexia (Phase 3)
Fatigue (Phase 3)
Lung Neoplasms (Phase 3)
Neoplasm Metastasis (Phase 3)
Prostatic Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)